Asset Search
Displaying all 6 assets.
-
Description Analyses of the area under the curve using the total UPDRS actual visit data showed similar, but not as significant, results (data not shown). Examination of the time until the subject was...
Article Title: Effects of Coenzyme Q10 in Early Parkinson Disease
Publication Title: Arch Neurol -
Description Figure 2 shows the course of the total UPDRS scores across the 16 months of the study with the last observation carried forward. By the 8-month visit, the scores had clearly separated and...
Article Title: Effects of Coenzyme Q10 in Early Parkinson Disease
Publication Title: Arch Neurol -
Description Eighty subjects were enrolled from May 24, 1999, through February 17, 2000 (Figure 1). At the baseline visit, the groups were well matched for sex, age, severity of PD (the UPDRS and Hoehn and Yahr...
Article Title: Effects of Coenzyme Q10 in Early Parkinson Disease
Publication Title: Arch Neurol -
Description All groups receiving coenzyme Q10 had highly significant increases in the mean plasma level of coenzyme Q10 from baseline to the last visit (Figure 5) (P.001), and the mean plasma levels of...
Article Title: Effects of Coenzyme Q10 in Early Parkinson Disease
Publication Title: Arch Neurol -
Description Results of the assay of the activity of complex I normalized to the activity of citrate synthetase did not indicate a significant effect of coenzyme Q10 (P = .73). In this assay, the activity of...
Article Title: Effects of Coenzyme Q10 in Early Parkinson Disease
Publication Title: Arch Neurol -
Description Figure 2 shows the course of the total UPDRS scores across the 16 months of the study with the last observation carried forward. By the 8-month visit, the scores had clearly separated and...
Article Title: Effects of Coenzyme Q10 in Early Parkinson Disease
Publication Title: Arch Neurol
Displaying all 6 assets.